1. Home
  2. AMTX vs KZIA Comparison

AMTX vs KZIA Comparison

Compare AMTX & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$3.53

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$13.41

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTX
KZIA
Founded
2005
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.6M
100.8M
IPO Year
2023
2002

Fundamental Metrics

Financial Performance
Metric
AMTX
KZIA
Price
$3.53
$13.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$12.00
$19.50
AVG Volume (30 Days)
1.6M
261.3K
Earning Date
05-11-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
32.98
N/A
EPS
N/A
N/A
Revenue
$77,194,000.00
N/A
Revenue This Year
$49.77
N/A
Revenue Next Year
$57.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
174.60
N/A
52 Week Low
$1.22
$3.05
52 Week High
$3.66
$17.40

Technical Indicators

Market Signals
Indicator
AMTX
KZIA
Relative Strength Index (RSI) 68.17 74.03
Support Level $2.17 $5.85
Resistance Level $3.60 $14.42
Average True Range (ATR) 0.25 1.32
MACD 0.07 0.24
Stochastic Oscillator 100.00 91.55

Price Performance

Historical Comparison
AMTX
KZIA

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: